BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
about
Renal Cancer Stem Cells: Characterization and Targeted TherapiesBMPs and their clinical potentialsRole of the PEBP4 protein in the development and metastasis of gastric cancer.BMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via mTORC1 pathwaySilencing BMP-2 expression inhibits A549 and H460 cell proliferation and migrationPromoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancerOrthotopic expression of noggin protein in cancer cells inhibits human lung carcinoma growth in vivo.BMP-2 induces EMT and breast cancer stemness through Rb and CD44.The Yin and Yang of bone morphogenetic proteins in cancer.Discovery of MicroRNAs associated with myogenesis by deep sequencing of serial developmental skeletal muscles in pigs.Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.BMP2-induced chemotaxis requires PI3K p55γ/p110α-dependent phosphatidylinositol (3,4,5)-triphosphate production and LL5β recruitment at the cytocortexInductive specification and axonal orientation of spinal neurons mediated by divergent bone morphogenetic protein signaling pathwaysThe impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28.ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancerBiological roles of human bone morphogenetic protein 9 in the bone microenvironment of human breast cancer MDA-MB-231 cellsIdentification of significant pathways in gastric cancer based on protein-protein interaction networks and cluster analysis.Bone morphogenetic proteins enhance an epithelial-mesenchymal transition in normal airway epithelial cells during restitution of a disrupted epithelium.Gastric stem cells and gastric cancer stem cells.Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiencyPromotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.rhBMP-2 has adverse effects on human oral carcinoma cell lines in vivo.BMP signaling and its paradoxical effects in tumorigenesis and dissemination.Bone morphogenic protein (BMP) signaling up-regulates neutral sphingomyelinase 2 to suppress chondrocyte maturation via the Akt protein signaling pathway as a negative feedback mechanismA Molecular View of Pathological Microcalcification in Breast Cancer.Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.Clonal heterogeneity in osteogenic potential of lung cancer-associated fibroblasts: promotional effect of osteogenic progenitor cells on cancer cell migration.miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.CRIM1, a newfound cancer-related player, regulates the adhesion and migration of lung cancer cells.BMP10 inhibited the growth and migration of gastric cancer cells.Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma.Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer.BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma.BMP-2 suppresses renal interstitial fibrosis by regulating epithelial-mesenchymal transition.Growth and differentiation factor 9 (GDF-9) induces epithelial-mesenchymal transition in prostate cancer cells.Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1.
P2860
Q26746970-08931779-B4BA-45C0-9BE8-127FFB469969Q26824827-531232D8-2459-4692-9BF7-65AFD9F2D64AQ33566865-47EE70E7-0910-4F57-9C4D-04AB8EFC75ECQ33657520-6006AF66-BE6A-4010-8B90-509E69386EA1Q33804283-9728ACDF-079C-4475-89FA-E509605D8168Q33841409-7EB457E9-5AA9-4BF3-A8EA-DC1FFA53650BQ33864133-3681BA9E-B372-44DB-BB48-FA79FC7361C2Q33907042-E6715952-2F5D-4A9F-A849-92E080EF8B47Q34127207-9C6BA2BD-E41C-487D-A8F6-598457328E80Q34533056-3EF8CB0B-AD96-4921-ACD3-74291EFDDB1DQ35142842-89A26D8D-29B7-4778-93A9-F0C06E0C7B39Q35178694-902359D1-3675-48FD-9083-D6C9B7BE264CQ35582686-ED8F3955-FAD9-4EAB-83AD-505E25A2C337Q35828140-B7A137EF-69AE-42FA-B949-DAAF5AA51869Q36140775-387B126F-EE8B-4337-BE1F-AD3D16A0347CQ36161802-6FC548EB-6343-463C-A929-115A60BFC0F7Q36225875-A9A0D940-CE50-4746-A29B-5874D647E125Q36283239-2F50E0B1-C240-4A69-9602-E067DE2585F4Q36715362-E73FD8FF-4BA8-4DDE-AE79-2435B14233D5Q36737793-58EF7039-9DF5-4445-A8BE-30E2BB63C4ABQ37305250-C219784D-47ED-44AA-B9C3-EE808C2787E9Q37439015-07D648DC-DFBB-487B-A160-A6C31B43B217Q37492007-EA4BD207-24CD-40D7-BEAA-979D71925B76Q37718513-D93BE879-A331-41A2-9483-F1E46524FBABQ38382977-0D987EAE-7CDB-410C-8CA7-B92B2DD97413Q38697305-03401596-01C3-4986-AA04-3520ADA9D7A3Q38712111-65C12114-033C-4C2B-A20D-4F09706BFC62Q38775092-0FE8049F-9A48-406C-9AE8-8B4B00B2058EQ38806667-67532002-F989-4355-A07B-F07420B38E05Q38812866-85713EF5-7149-403A-A5A3-5F1DFD579BB8Q38831476-00C2B06B-0FE3-4308-84FB-89AEE3C23E2FQ38836737-B3D96DBD-82F7-473C-BEA5-D4CC8ABA5AB1Q38905385-2D655AC9-D1A1-41B4-B866-8D17D07AE3F6Q38937195-A742CA14-8C2A-40F3-A137-0F2D7C148301Q38966417-0854F793-2343-4433-969D-AA350BB8F473Q39051557-8DD58C71-046A-4D5A-9578-B02DEAA08C3FQ39458618-724BA5B6-1E1B-44D2-91D3-EF2D38DB9C62Q39540601-7BA8523F-8788-4E6F-A796-7ACE4ED77E00Q39626062-7EEF49AD-4831-464F-96D1-60C4BD7DC9E6Q39654840-34FC2C3F-793D-4120-B91B-CD7D4A36C424
P2860
BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
BMP2 accelerates the motility ...... l 3-kinase (PI3K)/Akt pathway.
@en
BMP2 accelerates the motility ...... phosphatidylinositol 3-kinase
@nl
type
label
BMP2 accelerates the motility ...... l 3-kinase (PI3K)/Akt pathway.
@en
BMP2 accelerates the motility ...... phosphatidylinositol 3-kinase
@nl
prefLabel
BMP2 accelerates the motility ...... l 3-kinase (PI3K)/Akt pathway.
@en
BMP2 accelerates the motility ...... phosphatidylinositol 3-kinase
@nl
P2093
P1476
BMP2 accelerates the motility ...... l 3-kinase (PI3K)/Akt pathway.
@en
P2093
Ji Eun Seo
Jun Suk Kim
Myoung Hee Kang
Sang Cheul Oh
Young A Yoo
P356
10.1016/J.YEXCR.2009.10.010
P407
P577
2009-10-14T00:00:00Z